Damon E Houghton, Megan Keenan, Hayley Dykhoff, Kyle Campbell, Marie Hall, Heather Heaton, Kristine Thompson, Jamie Aranda, Sarah Balgord, Jonathan Rubin, Ali Raja, Sayon Dutta, Ryan Hanson, Dustin McEvoy, Wei He, Emily Cahill, Lisa Baumann Kreuziger, Rachel P Rosovsky
{"title":"多地点实施电子健康记录工具的主要发现,用于急诊科肺栓塞的临床预测概率。","authors":"Damon E Houghton, Megan Keenan, Hayley Dykhoff, Kyle Campbell, Marie Hall, Heather Heaton, Kristine Thompson, Jamie Aranda, Sarah Balgord, Jonathan Rubin, Ali Raja, Sayon Dutta, Ryan Hanson, Dustin McEvoy, Wei He, Emily Cahill, Lisa Baumann Kreuziger, Rachel P Rosovsky","doi":"10.1177/1358863X251337456","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The use of validated risk stratification tools for the workup of suspected pulmonary embolism (PE) is a recommendation of the American Society of Hematology and the American College of Emergency Physicians.</p><p><strong>Methods: </strong>We designed and implemented electronic clinical pretest probability (PTP) tools for use in emergency departments (ED). Overall, 38 EDs (tertiary and regional EDs) in the United States were involved across three health systems. PTP use was analyzed between September 12, 2022 and January 11, 2023 in 270,247 ED visits. PTP use was examined in terms of the percentage of visits for which patients underwent computed tomography pulmonary angiography (CTPA). Each site chose the 3-tier Wells' score for implementation and Site 2 designed a combined Wells', pulmonary embolism rule-out criteria (PERC), and YEARS score.</p><p><strong>Results: </strong>At Site 3, forced use resulted in documented PTP scores in 49-53% of ordered CTPAs. At Sites 1 and 2, where PTP scores were optional, documented PTP scores occurred in 2-3% and 1-3% of CTPA orders, respectively. At Site 1, the use of PTP increased slightly over the study period, with signs that PE yield on imaging was also increasing (3.4-5.9%). At Site 2, PE yield on imaging was 9-10%, and it remained similar, with similar use of PTP tools over the study period. PE yield (6-8%) on imaging also remained similar throughout the study at Site 3.</p><p><strong>Conclusions: </strong>Guideline-endorsed PTP scores for PE at three independent health systems in the United States did not increase PE yield on imaging. Novel implementation strategies involving interdisciplinary teams are urgently needed.</p>","PeriodicalId":23604,"journal":{"name":"Vascular Medicine","volume":"30 3","pages":"302-308"},"PeriodicalIF":3.0000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Key findings from multisite implementation of electronic health record tools for clinical pretest probability of pulmonary embolism in the emergency department.\",\"authors\":\"Damon E Houghton, Megan Keenan, Hayley Dykhoff, Kyle Campbell, Marie Hall, Heather Heaton, Kristine Thompson, Jamie Aranda, Sarah Balgord, Jonathan Rubin, Ali Raja, Sayon Dutta, Ryan Hanson, Dustin McEvoy, Wei He, Emily Cahill, Lisa Baumann Kreuziger, Rachel P Rosovsky\",\"doi\":\"10.1177/1358863X251337456\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The use of validated risk stratification tools for the workup of suspected pulmonary embolism (PE) is a recommendation of the American Society of Hematology and the American College of Emergency Physicians.</p><p><strong>Methods: </strong>We designed and implemented electronic clinical pretest probability (PTP) tools for use in emergency departments (ED). Overall, 38 EDs (tertiary and regional EDs) in the United States were involved across three health systems. PTP use was analyzed between September 12, 2022 and January 11, 2023 in 270,247 ED visits. PTP use was examined in terms of the percentage of visits for which patients underwent computed tomography pulmonary angiography (CTPA). Each site chose the 3-tier Wells' score for implementation and Site 2 designed a combined Wells', pulmonary embolism rule-out criteria (PERC), and YEARS score.</p><p><strong>Results: </strong>At Site 3, forced use resulted in documented PTP scores in 49-53% of ordered CTPAs. At Sites 1 and 2, where PTP scores were optional, documented PTP scores occurred in 2-3% and 1-3% of CTPA orders, respectively. At Site 1, the use of PTP increased slightly over the study period, with signs that PE yield on imaging was also increasing (3.4-5.9%). At Site 2, PE yield on imaging was 9-10%, and it remained similar, with similar use of PTP tools over the study period. PE yield (6-8%) on imaging also remained similar throughout the study at Site 3.</p><p><strong>Conclusions: </strong>Guideline-endorsed PTP scores for PE at three independent health systems in the United States did not increase PE yield on imaging. Novel implementation strategies involving interdisciplinary teams are urgently needed.</p>\",\"PeriodicalId\":23604,\"journal\":{\"name\":\"Vascular Medicine\",\"volume\":\"30 3\",\"pages\":\"302-308\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2025-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vascular Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/1358863X251337456\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/6/16 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vascular Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/1358863X251337456","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/16 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
Key findings from multisite implementation of electronic health record tools for clinical pretest probability of pulmonary embolism in the emergency department.
Background: The use of validated risk stratification tools for the workup of suspected pulmonary embolism (PE) is a recommendation of the American Society of Hematology and the American College of Emergency Physicians.
Methods: We designed and implemented electronic clinical pretest probability (PTP) tools for use in emergency departments (ED). Overall, 38 EDs (tertiary and regional EDs) in the United States were involved across three health systems. PTP use was analyzed between September 12, 2022 and January 11, 2023 in 270,247 ED visits. PTP use was examined in terms of the percentage of visits for which patients underwent computed tomography pulmonary angiography (CTPA). Each site chose the 3-tier Wells' score for implementation and Site 2 designed a combined Wells', pulmonary embolism rule-out criteria (PERC), and YEARS score.
Results: At Site 3, forced use resulted in documented PTP scores in 49-53% of ordered CTPAs. At Sites 1 and 2, where PTP scores were optional, documented PTP scores occurred in 2-3% and 1-3% of CTPA orders, respectively. At Site 1, the use of PTP increased slightly over the study period, with signs that PE yield on imaging was also increasing (3.4-5.9%). At Site 2, PE yield on imaging was 9-10%, and it remained similar, with similar use of PTP tools over the study period. PE yield (6-8%) on imaging also remained similar throughout the study at Site 3.
Conclusions: Guideline-endorsed PTP scores for PE at three independent health systems in the United States did not increase PE yield on imaging. Novel implementation strategies involving interdisciplinary teams are urgently needed.
期刊介绍:
The premier, ISI-ranked journal of vascular medicine. Integrates the latest research in vascular biology with advancements for the practice of vascular medicine and vascular surgery. It features original research and reviews on vascular biology, epidemiology, diagnosis, medical treatment and interventions for vascular disease. A member of the Committee on Publication Ethics (COPE)